Xiandong Lin

Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432

F. Wang, Xiaoli Wei, Fenggong Wang et al. · Annals of Oncology · 2019 · 466 citations · Full text

Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease

Wenying Qiu, Xiaoyun Guo, Xiandong Lin et al. · Neurobiology of Aging · 2017 · 98 citations · Full text

Alzheimer's Disease, Medicine, Dementia +6

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer

Gen Lin, Xirong Fan, Weifeng Zhu et al. · Oncotarget · 2017 · 83 citations · Full text

Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non–Small Cell Lung Cancer

Chao Li, Cheng Huang, Tony Mok et al. · Journal of Thoracic Oncology · 2017 · 68 citations · Full text

Tumor Biology, Pd-l1 Expression, Medicine +12

TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib

Wenxian Wang, C. Xu, Yanping Chen et al. · Journal of Thoracic Disease · 2018 · 68 citations · Full text